HSIC

Henry Schein, Inc.

• Simply Wall St·15h ago

  Henry Schein (HSIC) Could Be 16% Undervalued On Higher Margin Growth Story

• NASDAQ·6d ago

  Henry Schein Moves Up In Market Cap Rank, Passing Federal Realty Investment Trust

• TipRanks·6d ago

  Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Arcus Biosciences (RCUS) and Incyte (INCY)

• Dow Jones·10/20 10:35

  Press Release: Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET

• Dow Jones·10/19 20:35

  Henry Schein Inc. Stock Slips 2.8%, Underperforms Peers

• Simply Wall St·10/19 13:30

  How CFO Change At Henry Schein (HSIC) Has Changed Its Investment Story

• NASDAQ·10/19 12:45

  Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

• Simply Wall St·10/15 12:31

  Why Henry Schein (HSIC) Is Getting Attention Now

• Dow Jones·10/14 20:47

  Henry Schein Price Target Cut to $92.00/Share From $96.00 by Leerink Partners

• Dow Jones·10/14 20:47

  Henry Schein Is Maintained at Market Perform by Leerink Partners

• Benzinga·10/14 20:37

  Leerink Partners Maintains Market Perform on Henry Schein, Lowers Price Target to $92

• TipRanks·10/14 12:50

  Henry Schein price target lowered to $92 from $96 at Leerink

• TipRanks·10/12 12:20

  Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Pharvaris (PHVS) and Tenet Healthcare (THC)

• TipRanks·10/12 09:50

  Analysts Offer Insights on Healthcare Companies: Nektar Therapeutics (NKTR), Roche Holding AG (OtherRHHVF) and Henry Schein (HSIC)

• Simply Wall St·10/12 06:25

  New CFO Appointment Might Change The Case For Investing In Henry Schein Stock (HSIC)